Cost-Effectiveness Analysis of Regorafenib in Patients with Advanced Hepatocellular Carcinoma
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.184
https://www.valueinhealthjournal.com/article/S1098-3015(18)30484-4/fulltext
Section Title :
Section Order :
1032
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30484-4&doi=10.1016/j.jval.2018.04.184